Advertisement

Annals of Surgical Oncology

, Volume 25, Issue 12, pp 3660–3666 | Cite as

Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers

  • Tak Kyu Oh
  • YoungRok Choi
  • Ah-Young Oh
  • Seung Hyun Chung
  • Sunghee Han
  • Jung-Hee Ryu
Thoracic Oncology
  • 40 Downloads

Abstract

Background

Elevated high-sensitivity C-reactive protein (hsCRP) levels are known to be associated with a poor prognosis for cancer patients, but inadequate data exist regarding whether pre- or postoperative hsCRP levels have better predictive value after oncologic surgery. This study evaluated the associations between pre- and postoperative hsCRP levels and 90-day postoperative mortality among patients who underwent surgery for abdominal or thoracic cancers.

Methods

This retrospective cohort study included 7933 patients who underwent elective surgery between January 2010 and December 2016. Cox regression analysis and receiver operative characteristic curve analyses were used to evaluate the prognostic values of preoperative hsCRP (< 1 month before surgery) and postoperative hsCRP (< 3 days after surgery).

Results

For predicting 90-day mortality, the area under the receiver operating characteristic curve was significantly larger for preoperative hsCRP than for postoperative hsCRP [0.76; 95% confidence interval (CI) 0.71–0.81 vs 0.65 95% CI 0.57–0.72; P < 0.001]. The optimal cutoff values were 0.5 mg/dL for preoperative hsCRP and 9.7 mg/dL for postoperative hsCRP. Based on these cutoff values, increased risks of 90-day mortality were significantly associated with preoperative hsCRP levels higher than 0.5 mg/dL [hazard ratio (HR) 7.60; 95% CI 4.43–13.03; P < 0.001] and postoperative hsCRP levels higher than > 9.7 mg/dL (HR 1.83; 95% CI 1.12–2.98; P = 0.016).

Conclusion

Both elevated pre- and postoperative hsCRP levels were associated with increased risks of 90-day mortality after surgery for thoracic and abdominal cancer. However, preoperative hsCRP had better prognostic value than postoperative hsCRP.

Notes

Disclosure

The authors declare that they have no conflict of interest.

Supplementary material

10434_2018_6734_MOESM1_ESM.docx (15 kb)
Supplementary material 1 (DOCX 14 kb)
10434_2018_6734_MOESM2_ESM.docx (16 kb)
Supplementary material 2 (DOCX 15 kb)

References

  1. 1.
    Guo YZ, Pan L, Du CJ, Ren DQ, Xie XM. Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. Asian Pac J Cancer Prev. 2013;14:243–8.CrossRefGoogle Scholar
  2. 2.
    Siemes C, Visser LE, Coebergh JW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol. 2006;24:5216–22.CrossRefGoogle Scholar
  3. 3.
    Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6:149–63.CrossRefGoogle Scholar
  4. 4.
    Koike Y, Miki C, Okugawa Y, et al. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol. 2008;98:540–4.CrossRefGoogle Scholar
  5. 5.
    Roxburgh CS, Crozier JE, Maxwell F, et al. Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer. Br J Cancer. 2009;100:701–6.CrossRefGoogle Scholar
  6. 6.
    Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC. Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer. Eur J Cancer. 2009;45:2138–45.CrossRefGoogle Scholar
  7. 7.
    Crumley AB, McMillan DC, McKernan M, Going JJ, Shearer CJ, Stuart RC. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer. 2006;94:1568–71.CrossRefGoogle Scholar
  8. 8.
    Gockel I, Dirksen K, Messow CM, Junginger T. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. WJG World J Gastroenterol. 2006;12:3746–50.CrossRefGoogle Scholar
  9. 9.
    Guillem P, Triboulet JP. Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus I.S.D.E. 2005;18:146–50.CrossRefGoogle Scholar
  10. 10.
    Jamieson NB, Glen P, McMillan DC, et al. Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer. 2005;92:21–3.CrossRefGoogle Scholar
  11. 11.
    Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813–8.CrossRefGoogle Scholar
  12. 12.
    Casadei Gardini A, Carloni S, Scarpi E, et al. Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial. Oncotarget. 2016;7:10193–202.PubMedGoogle Scholar
  13. 13.
    Ko YJ, Kwon YM, Kim KH, et al. High-sensitivity C-reactive protein levels and cancer mortality. Cancer Epidemiol Biomarkers Prev. 2012;21:2076–86.CrossRefGoogle Scholar
  14. 14.
    de Martino M, Klatte T, Seemann C, et al. Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC). BJU Int. 2013;111: E348–53.CrossRefGoogle Scholar
  15. 15.
    Cabellos Olivares M, Labalde Martinez M, Torralba M, Rodriguez Fraile JR, Atance Martinez JC. C-reactive protein as a marker of the surgical stress reduction within an ERAS (Enhanced Recovery After Surgery) protocol in colorectal surgery: a prospective cohort study. J Surg Oncol. 2018;117: 717–24.CrossRefGoogle Scholar
  16. 16.
    Kroll D, Nakhostin D, Stirnimann G, et al. C-Reactive protein on postoperative day 1: a predictor of early intraabdominal infections after bariatric surgery. Obes Surg. 2018;28:2760–2766.CrossRefGoogle Scholar
  17. 17.
    Pastorino U, Morelli D, Leuzzi G, et al. Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer. Eur J Cancer. 2017;79:90–7.CrossRefGoogle Scholar
  18. 18.
    DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.CrossRefGoogle Scholar
  19. 19.
    van Dijk WD, Akkermans R, Heijdra Y, et al. The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients. Biomark Med. 2013;7:211–9.CrossRefGoogle Scholar
  20. 20.
    Shi Q, Pavey ES, Carter RE. Bonferroni-based correction factor for multiple, correlated endpoints. Pharm Stat. 2012;11:300–9.CrossRefGoogle Scholar
  21. 21.
    Lee S, Choe JW, Kim HK, Sung J. High-sensitivity C-reactive protein and cancer. J Epidemiol. 2011;21:161–8.CrossRefGoogle Scholar
  22. 22.
    Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493–503.CrossRefGoogle Scholar
  23. 23.
    Schwartsburd PM. Chronic inflammation as inductor of pro-cancer microenvironment: pathogenesis of dysregulated feedback control. Cancer Metastasis Rev. 2003;22:95–102.CrossRefGoogle Scholar
  24. 24.
    Slaviero KA, Clarke SJ, Rivory LP. Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol. 2003;4:224–32.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Tak Kyu Oh
    • 1
  • YoungRok Choi
    • 2
  • Ah-Young Oh
    • 1
    • 3
  • Seung Hyun Chung
    • 1
  • Sunghee Han
    • 1
    • 3
  • Jung-Hee Ryu
    • 1
    • 3
  1. 1.Department of Anesthesiology and Pain MedicineSeoul National University Bundang HospitalSeongnamKorea
  2. 2.Department of SurgerySeoul National University Bundang HospitalSeongnamKorea
  3. 3.Department of Anesthesiology and Pain MedicineSeoul National University College of MedicineSeoulKorea

Personalised recommendations